PHARMA MAR, S.A. The price-sensitive information presented in other languages is a literal translation of the price-sensitive information stated in Spanish 31/03/2016 08:26 PHARMA MAR, S.A. R&D: new licenses, patents and registered trademarks Resultados del ensayo clínico de Fase III de Aplidin® en pacientes con mieloma múltiple en recaída o refractario. Register number: 236798
